Efficacy of targeted lung denervation in patients with moderate to severe COPD

被引：0
|
作者：
Slebos, Dirk-Jan
Klooster, Karin
Koegelenberg, Coenraad
Theron, Johan
Steyn, Dorothy
Mayse, Martin
Bolliger, Chris
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
COPD; -; management; Bronchoscopy; Lung function testing;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1774
引用
收藏
页数：5
相关论文
共 50 条
  • [31] A SYSTEMATIC LITERATURE REVIEW OF THE CLINICAL EFFICACY OF TRIPLE THERAPY FOR MODERATE TO SEVERE COPD PATIENTS
    Kaur, G.
    Verma, M.
    Sharma, S.
    Magni, T.
    Orlovic, M.
    VALUE IN HEALTH, 2022, 25 (01) : S31 - S31
  • [32] Effect of aclidinium bromide on static lung function and hyperinflation in patients with moderate to severe COPD
    Watz, Henrik
    Beeh, Kai M.
    Magnussen, Helgo
    de Theresa, Luis
    Jarreta, Diana
    Caracta, Cynthia
    Garcia, Esther
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [33] Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD
    Maltais, Francois
    Celli, Bartolome
    Casaburi, Richard
    Porszasz, Janos
    Jarreta, Diana
    Seoane, Beatriz
    Caracta, Cynthia
    RESPIRATORY MEDICINE, 2011, 105 (04) : 580 - 587
  • [34] Crossover Patient Outcomes for Targeted Lung Denervation in Moderate to Severe Chronic Obstructive Pulmonary Disease: AIRFLOW-2
    Conway, Francesca
    Tonkin, James
    Valipour, Arschang
    Pison, Christophe
    Schumann, Christian
    Bonta, Peter, I
    Kessler, Romain
    Gesierich, Wolfgang
    Darwiche, Kaid
    Lamprecht, Bernd
    Skowasch, Dirk
    Johnson, Philip J.
    Slebos, Dirk-Jan
    Shah, Pallav L.
    RESPIRATION, 2022, 101 (11) : 1069 - 1074
  • [35] EFFECTS OF INDACATEROL/GLYCOPYRRONIUM ON LUNG FUNCTION AND PHYSICAL ACTIVITY IN PATIENTS WITH MODERATE TO SEVERE COPD
    Watz, H.
    Mailaender, C.
    Kirsten, A-M
    THORAX, 2015, 70 : A146 - A147
  • [36] Computed tomographic airway morphology after targeted lung denervation treatment in COPD
    Hartman, Jorine E.
    Herth, Felix J. F.
    Shah, Pallav
    Pison, Christophe
    Valipour, Arschang
    Slebos, Dirk-Jan
    RESPIRATORY MEDICINE, 2023, 206
  • [37] Rate of lung function decline slows in the 3 years after targeted lung denervation in COPD
    Hartman, Jorine E.
    Conway, Francesca
    Degano, Bruno
    Augustijn, Sonja W. S.
    Herth, Felix J. F.
    Mayr, Anna
    Chacaroun, Samarmar
    Tonkin, James
    Valipour, Arschang
    Slebos, Dirk-Jan
    RESPIRATORY MEDICINE, 2021, 188
  • [38] Effect of budesonide/formoterol on severe exacerbations and lung function in moderate to severe COPD
    Calverley, PMA
    THORAX, 2002, 57
  • [39] Efficacy And Safety Of Indacaterol 75 G Once Daily In Patients With Moderate-To-Severe COPD
    Kerwin, E. M.
    Meli, J.
    Peckitt, C.
    Lassen, C.
    Kramer, B.
    Filcek, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [40] One-Year Safety and Efficacy Study of Arformoterol Tartrate in Patients With Moderate to Severe COPD
    Donohue, James F.
    Hanania, Nicola A.
    Make, Barry
    Miles, Matthew C.
    Mahler, Donald A.
    Curry, Lisa
    Tosiello, Robert
    Wheeler, Alistair
    Tashkin, Donald P.
    CHEST, 2014, 146 (06) : 1531 - 1542
12345